{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T16:37:36Z","timestamp":1787071056213,"version":"build-2736575974"},"reference-count":20,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,10]]},"abstract":"<jats:sec>\n                    <jats:title>Aims:<\/jats:title>\n                    <jats:p>This study aimed to evaluate the feasibility and outcomes of patients with advanced cervical cancer treated with definitive concurrent chemoradiotherapy followed by Type C 1 nerve-sparing radical hysterectomy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Settings and Design:<\/jats:title>\n                    <jats:p>This is a prospective study to assess the feasibility of Type C 1 nerve-sparing radical hysterectomy postdefinitive chemoradiation in advanced carcinoma cervix.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Subjects and Methods:<\/jats:title>\n                    <jats:p>We analyzed 25 patients with cervical cancer evaluated and treated with concurrent chemoradiation followed by surgery. Twenty patients underwent Type C 1 nerve-sparing radical hysterectomy by open surgery and five patients by laparoscopic approach. Postoperative morbidity and pathology were analyzed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Statistical Analysis Used:<\/jats:title>\n                    <jats:p>Analysis of the outcomes was done by arithmetical calculations.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>Eight patients (32%) had persistent residual disease after definitive chemoradiation followed by surgery. Rest of the patients had pathological complete response. Two patients (8%) had node-positive disease. None of the patients in the laparoscopic group had bladder morbidity. One patient in the laparoscopic group had persistent vaginal discharge.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>Type C1 nerve-sparing radical hysterectomy is technically feasible with minimal morbidity following definitive chemoradiation in advanced squamous cell carcinoma of the cervix.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/jcrt.jcrt_557_20","type":"journal-article","created":{"date-parts":[[2021,8,3]],"date-time":"2021-08-03T04:26:59Z","timestamp":1627964819000},"page":"1559-1563","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Type C1 radical hysterectomy in advanced squamous cell carcinoma of the cervix postdefinitive concurrent chemoradiation"],"prefix":"10.4103","volume":"18","author":[{"given":"Gouthaman Shanmuga","family":"Sundaram","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Snehalatha","family":"Kothari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sri Karthik","family":"Voleti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vijay","family":"Krishna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jagadesh Chandra","family":"Bose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-17-20241021","doi-asserted-by":"crossref","first-page":"69","DOI":"10.3322\/caac.20107","article-title":"Global cancer statistics","volume":"61","author":"Jemal","year":"2011","journal-title":"CA Cancer J Clin"},{"key":"R2-17-20241021","first-page":"S43","article-title":"Carcinoma of the cervix uteri. FIGO 26th annual report on the results of treatment in gynecological cancer","volume":"95","author":"Quinn","year":"2006","journal-title":"Int J Gynaecol Obstet"},{"key":"R3-17-20241021","doi-asserted-by":"crossref","first-page":"S100","DOI":"10.1016\/S0020-7292(12)60023-X","article-title":"Cancer of the cervix uteri","volume":"119","author":"Wiebe","year":"2012","journal-title":"Int J Gynaecol Obstet"},{"key":"R4-17-20241021","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.ijgo.2013.07.041","article-title":"Surgical morbidity and oncologic results after concurrent chemoradiation therapy for advanced cervical cancer","volume":"125","author":"Sun","year":"2014","journal-title":"Int J Gynaecol Obstet"},{"key":"R5-17-20241021","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1111\/IGC.0b013e3181c9e385","article-title":"Results of surgery after concurrent chemoradiotherapy in advanced cervical cancer: Comparison of extended hysterectomy and extrafascial hysterectomy","volume":"20","author":"Motton","year":"2010","journal-title":"Int J Gynecol Cancer"},{"key":"R6-17-20241021","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1038\/sj.bjc.6604619","article-title":"Adjuvant hysterectomy for treatment of residual disease in patients with cervical cancer treated with radiation therapy","volume":"99","author":"Ota","year":"2008","journal-title":"Br J Cancer"},{"key":"R7-17-20241021","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1634\/theoncologist.2009-0295","article-title":"Prognostic factors and morbidities after completion surgery in patients undergoing initial chemoradiation therapy for locally advanced cervical cancer","volume":"15","author":"Touboul","year":"2010","journal-title":"Oncologist"},{"key":"R8-17-20241021","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1634\/theoncologist.2011-0276","article-title":"Results of the GYNECO 02 study, an FNCLCC phase III trial comparing hysterectomy with no hysterectomy in patients with a (clinical and radiological) complete response after chemoradiation therapy for stage IB2 or II cervical cancer","volume":"17","author":"Morice","year":"2012","journal-title":"Oncologist"},{"key":"R9-17-20241021","doi-asserted-by":"crossref","first-page":"S127","DOI":"10.1016\/j.ygyno.2007.07.006","article-title":"Preoperative concomitant chemoradiotherapy in locally advanced cervical cancer: Safety, outcome, and prognostic measures","volume":"107","author":"Ferrandina","year":"2007","journal-title":"Gynecol Oncol"},{"key":"R10-17-20241021","doi-asserted-by":"crossref","first-page":"e40","DOI":"10.3802\/jgo.2016.27.e40","article-title":"Extrafascial hysterectomy after concurrent chemoradiotherapy in locally advanced cervical adenocarcinoma","volume":"27","author":"Yang","year":"2016","journal-title":"J Gynecol Oncol"},{"key":"R11-17-20241021","first-page":"319","article-title":"The value of laparoscopic surgery to stage gynecological cancers: Present and future","volume":"61","author":"Mettler","year":"2009","journal-title":"Minerva Ginecol"},{"key":"R12-17-20241021","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1245\/s10434-016-5489-4","article-title":"The role of laparoscopic radical hysterectomy in early-stage adenocarcinoma of the uterine cervix","volume":"23","author":"Park","year":"2016","journal-title":"Ann Surg Oncol"},{"key":"R13-17-20241021","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1097\/IGC.0000000000000052","article-title":"Comparison of laparoscopic versus abdominal radical hysterectomy for FIGO stage IB and IIA cervical cancer with tumor diameter of 3 cm or greater","volume":"24","author":"Kong","year":"2014","journal-title":"Int J Gynecol Cancer"},{"key":"R14-17-20241021","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1016\/j.jmig.2014.03.020","article-title":"Nerve-sparing radical hysterectomy made easy by laparoscopy","volume":"21","author":"Puntambekar","year":"2014","journal-title":"J Minim Invasive Gynecol"},{"key":"R15-17-20241021","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1056\/NEJMoa1806395","article-title":"Minimally invasive versus abdominal radical hysterectomy for cervical cancer","volume":"379","author":"Ramirez","year":"2018","journal-title":"N Engl J Med"},{"key":"R16-17-20241021","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.ygyno.2005.12.013","article-title":"Total laparoscopic radical hysterectomy and lymphadenectomy: The M. D. Anderson Cancer Center experience","volume":"102","author":"Ramirez","year":"2006","journal-title":"Gynecol Oncol"},{"key":"R17-17-20241021","first-page":"393","article-title":"Laparoscopic surgery in treatment of stage IIb cervical cancer after neoadjuvant chemotherapy. A case report and review of the literature","volume":"24","author":"Malzoni","year":"2003","journal-title":"Eur J Gynaecol Oncol"},{"key":"R18-17-20241021","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1093\/molehr\/gas058","article-title":"Spontaneous germline potential of human hepatic cell line in vitro","volume":"19","author":"Ma","year":"2013","journal-title":"Mol Hum Reprod"},{"key":"R19-17-20241021","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1200\/JCO.2017.75.9985","article-title":"Neoadjuvant chemotherapy followed by radical surgery versus concomitant chemotherapy and radiotherapy in patients with stage IB2, IIA, or IIb squamous cervical cancer: A randomized controlled trial","volume":"36","author":"Gupta","year":"2018","journal-title":"J Clin Oncol"},{"key":"R20-17-20241021","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1136\/ijgc-2019-000890","article-title":"Oncologic outcome after completing or abandoning (radical) hysterectomy in patients with cervical cancer and intraoperative detection of lymph node positivity; ABRAX (ABandoning RAd hyst in cerviX cancer)","volume":"30","author":"Dostalek","year":"2020","journal-title":"Int J Gynecol Cancer"}],"container-title":["Journal of Cancer Research and Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/jcrt.JCRT_557_20","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T15:40:51Z","timestamp":1787067651000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/jcrt.JCRT_557_20"}},"subtitle":["An argument"],"short-title":[],"issued":{"date-parts":[[2022,10]]},"references-count":20,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.4103\/jcrt.jcrt_557_20","relation":{},"ISSN":["0973-1482"],"issn-type":[{"value":"0973-1482","type":"print"}],"subject":[],"published":{"date-parts":[[2022,10]]}}}